AnalystsInsight

Paul Matteis (Stifel Nicolaus): Analyst Track Record and Price‑Target Accuracy

How often Paul Matteis’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,155 ratings, compared with the average Wall Street analyst.

Reviewed by:David, Senior AnalystPublished Oct 12, 2026Updated Oct 20, 20263 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#1046 rank (was #1116)+6 new ratings (XENE, RAPP, DFTX)+1 stock newly covered

Key takeaways

Paul Matteis ranks #902 of 1,000 analysts in Exent’s scoring (4.5★).
42.0% of price targets were reached over 7 years, versus 52.4% for the average analyst.
Median time to reach a target: 100 days; 51.1% of calls were up 12 months later.
Most‑covered stocks: XENE, BMRN, BIIB, QURE.
Free on Exent: Paul Matteis’s full record, with ratings 3 days after publication.

In this article

Paul Matteis’s track record at a glance
How fast price targets were reached
Stocks Paul Matteis covers most
Paul Matteis’s latest ratings
How Exent scores analysts

Paul Matteis’s track record at a glance

Paul Matteis of Stifel Nicolaus ranks #902 of the 1,000 analysts Exent scores, with a 4.5★ rating and a focus on healthcare. Over a 7‑year lookback, 42.0% of Paul’s price targets were reached, 10.4 points below the 52.4% average across all analysts.

Metric	Paul Matteis	All analysts
Price‑target hit rate	42.0%	52.4%
Median days to hit target	100 days	91 days
Calls up after 12 months	51.1%	64.0%
Median 12‑month return of calls	+0.9%	+13.4%
Hit rate, last 2 years	35.2%	—
Average worst drop after a call	−27.6%	—
Ratings in the sample	1,155	—
Stocks covered	36	—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

See the top-ranked analysts in Gems

How fast price targets were reached

Time to reach the target	Paul Matteis
Under 30 days	20.1%
30–90 days	26.3%
90–180 days	32.6%
Over 180 days	21.1%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Paul Matteis covers most

Stock	Ratings in the sample
XENE	27
BMRN	22
BIIB	22
QURE	20
DNLI	20
NBIX	20
PEPG	17
VRTX	17

In the past year Paul’s ratings were 77% Buy, 23% Hold and 0% Sell.

Paul Matteis’s latest ratings

Date	Stock	Action	Rating	Price target
Sep 18, 2026	XENE	Reiterated: Buy	Buy	$0.00
Sep 16, 2026	RAPP	Reiterated: Buy	Buy	$56.00
Sep 15, 2026	DFTX	Reiterated: Buy	Buy	$67.00
Sep 15, 2026	CTNM	Reiterated: Buy	Buy	$28.00
Sep 15, 2026	SION	Reiterated: Hold	Hold	$7.00
Sep 14, 2026	KRSA	Initiated Coverage: Buy	Buy	$43.00
Sep 8, 2026	DYN	Reiterated: Buy	Buy	$37.00
Aug 31, 2026	ALNY	Reiterated: Buy	Buy	$318.00
Aug 31, 2026	BMRN	Reiterated: Hold	Hold	$70.00
Aug 31, 2026	DFTX	Reiterated: Buy	Buy	$60.00
Aug 14, 2026	CTNM	Reiterated: Buy	Buy	$28.00
Aug 13, 2026	RAPP	Reiterated: Buy	Buy	$56.00

Sep 18, 2026
Stock
XENE
Action
Reiterated: Buy
Rating
Buy
Price target
$0.00
Sep 16, 2026
Stock
RAPP
Action
Reiterated: Buy
Rating
Buy
Price target
$56.00
Sep 15, 2026
Stock
DFTX
Action
Reiterated: Buy
Rating
Buy
Price target
$67.00
Sep 15, 2026
Stock
CTNM
Action
Reiterated: Buy
Rating
Buy
Price target
$28.00
Sep 15, 2026
Stock
SION
Action
Reiterated: Hold
Rating
Hold
Price target
$7.00
Sep 14, 2026
Stock
KRSA
Action
Initiated Coverage: Buy
Rating
Buy
Price target
$43.00
Sep 8, 2026
Stock
DYN
Action
Reiterated: Buy
Rating
Buy
Price target
$37.00
Aug 31, 2026
Stock
ALNY
Action
Reiterated: Buy
Rating
Buy
Price target
$318.00
Aug 31, 2026
Stock
BMRN
Action
Reiterated: Hold
Rating
Hold
Price target
$70.00
Aug 31, 2026
Stock
DFTX
Action
Reiterated: Buy
Rating
Buy
Price target
$60.00
Aug 14, 2026
Stock
CTNM
Action
Reiterated: Buy
Rating
Buy
Price target
$28.00
Aug 13, 2026
Stock
RAPP
Action
Reiterated: Buy
Rating
Buy
Price target
$56.00

Paul’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

See the top-ranked analysts in Gems

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

Exent Gems shows Paul Matteis’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

See this week’s Gems

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Paul Matteis ranks #902 of 1,000 with a 4.5★ rating. 42.0% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 51.1% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Paul Matteis’s success rate is 45.3% by the ranking source and 42.0% by Exent’s price-target hit-rate backtest, with a median of 100 days to reach a target.

Paul Matteis (Stifel Nicolaus) covers 36 stocks, mostly in healthcare. The most frequently rated are XENE, BMRN, BIIB, QURE, DNLI.

: .-++++=: .-=+**+-. .:=+*#*=:..::-+##*+-:. .-+**+++=:. .:::-=+**********++===++***+++*###*+=--:. .:==+*#*+-:..::-+##*+-:. :=**++=: .-=+**+-. .:=+*#*-...: . -++*+=: .:=+**+-. .:-+*#*=:..::=+##*=-:...:=***++=:. .:-=+*###*++==--:::::::...:---==+*##**++=-. .:-=+###*=-:...-+**++=: :=++*+-. :-=***=:..:-=*##+-..: :=+*++-. :=++*+=. :-=*#*+-..::=+##*=-:...-+*#*+=-. :-=+*###*+=--:. .... .::..:-=+++****=-:..::-=*#*+=-: .-=++++=. .-=+**+-...:=+##*=:.::-+##*=::. .-++++=: .-=+**=: .-=+*#+-...:-+##*=-::.:-+##*+=:. .-=++***+=-:::.. ..:-----:::::::. .:-=+*###*=-:.. :=+**++-. .-=+**+-. .:-+*##+:..:-=*##+-:..:=*#*+-:. :=+*++-. :=+**+-. .:=+*#*-...:-+*##+-:.::-+##*=-:. :=++**++-:...::::-==+++++****++===-:....:::-+*#*+==:. .-=+**+-. .:-=*##+-:.::-+##*=::.:-+##*=-:..-+#*+=:. .-++++=: .-++**=: :-=***=:..:-=*##+-:.::-+##*=-:...:=***++-: .:-==*###**+**####*******+=-::...:-+**++=-. :-=+##*-:..:-+###+-:..:=*#*+-:..:=*#*=-: :=**+=-. :=++++-. :=+**+-. .-=+**+-...-=+##*-:.::-+##*=-:...-+***+=-. .:-=+*####*+==========++*###*+=-:. .-=+***+-...:-=*##+-::.:-*##+=-:..-+#*+=-. .-+**+=: .-++++=: :=+*+=: .-=+**=: :-+***=: .:-+*#*=:..:-+###+-::.:-+##*=-:. .-=++****+---::. .::::--+****++=-. .:-+*##+-::.:-+##*=-:..:=*#*+-: .=**++-. :=+*++-. :=+**+: -++*+=. :=+**+-. .-=+**+-..:-=*##+-..:-=*##+-::.:-+##*=-:. :=+++*++-:...:.. ...:.. .:-=+**#*=:..::-+##*+-:...-+#*+=-. -+**+=: .-++*+=: .-++*+=. :=+**+- =+**+- .-=+**=: :-=*#*=:..:-+*#*=:.::-+##*=::.:-+##*=-:. .-+**++=-: .::---====---:. .::-=*##*=-:...-+##+=-: :=+*++-. .=++++-. :=+**+-. .-=+**+: .:-=*#*= =+**=: :-=***=. .:=+*#+-..:-=*##+-..:-=*##+-:.::=*##+-:...-+**++=:. .:-==+*###*+++++=-:..:::=*##*=-:. .-+**+=: -=+*+=: .-=+**=: :-=*#*=. .:=+*#+-..:-=*##+ =+**=. .:=+**+-. .-=*##+:..:-+*#*=:.::-+##*-::::=*##+=::..-+##*=-: :-=++*###**+++*###*=-::. .-+**+=-. :=++*+=. :-+**+-. .:=+*#+-..:-=*##+:..:-+##*=:.::=*##+ +**+-. .-=+**+:..:-+*#*=:..:=+##+-:.:-=*##+-:.:-+##*=-:..:+*#*=-:. .:=++***+=------=+*##*+=-. .-++*+=: .-=+**+: .-=*#*=:..:-+*#*=:.::=*##+-:.:-+##*=::.:-*##+ +**+-. :-=*#*=:..:-+##*-..:-=*##+-:.:-+##*=::.:-*##+-:..:=*#*+-:. .-+**++=-:. ..:...:-=+*++=-. :-+***=. .:-+*#*-...:=+##+-..:-=*#*=::::-+##+-::.:=*#*=-:..-+##+ +*#+:..:-+*#*=:..:=*##+-:.:-+##*=::::-*##+-:..:=*#*=-:..:+##+=-. .:+**++-: .::::. :-++**+:. .-=+##+:..:-=*#*=:..:-+##*-::::=*##+-:.:-+##*=::.:=*#*+-:..:+##+ *##+:..:-+##*-:.::=*##+-:::-+##*=::.:=*##+-:..-+##*=-...-*#*+-:. .=***+-: :-====-: .:-+*#*=:..:-+##*-:.::=*##+-:.:-+##*=::.:=*##+-:..:+##+=-...-*#*+-:. :+**+ *##=:..:-+##*-:.::=*##=-:.:-+##+-:..:=*#*=-:..-+##+=:. :=*#*=-: :+**+=:. .-=++**#*+-..:-=*##+-:.:-+##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+ *##=::::-+##+-::::=##*=-:.:-*##+-:..:=##*=-:..-+#*+-:. :=**+=-. .-+**+=: :=+*+++##*=::::=*##+-:.::+##*=-:.:-*##+-:..:+##*=-...-*#*+-: :=**+=-. .-+*++-. :=+*+ ##*=::.:-*##+-:..:=##*=-:..-*#*+-:..:=*#+=-. .-+**+-: :=**+=-. .-+*++=. :=++++*##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+=: .-+*++-. :=+++ ##*=-:..-*##+-:..:=*#*=-...-+#*+-:. :=**+=-. .-+**+=: .=+*+=-. -=+*+=: .-=+*###*=-:..:=*#*=-:..-+##+=:...=*#*=-: :+**+=:. .-+*++-. :=**+=: .-++++-. :=+** ##*=-:..-+#*+-:. :=**+=-. .-+**+=: .=**+=-. :++++=: .-++*+-. :=+**+-. .:--=++=-:::.:-*##+=:...-*#*+-:. :=**+=-. -+**+=: .=+*+=-. :=+++=: .-++*+-. .-=+** *#*=-: .-+**+=:. .=**+=-. :+**+=: .-++++-. :=+**+: .-=+**=: :-=+##+-:...........::-+##*=-:..:=*#*=-. :+**+=:. .-+*++-. :=+*+=- .-++*+=. :=+**+- .-=+** ***=-. :+**+=: .-+*++-. :=+++=: .-=+*+=. :-+**+-. .:=+*#*-:..:-+*##*=--:. .:--=*##*=-:...-*#*+=:. .-+**+-: .=+*+=-. :=+*+=: .-++*+-. :=+**+: :-=*** +*++-. :=+*+=: .-++*+=. :=+**+-. .:=+**+: :-=*#*+:..:-=*##+-::.:-=*##*+==------==+*##*=-:...-+##+=-. :+**+=-. :++*+=: .-++*+=. :=+**+-. .-=+**=: .:-+*#* ++++=: :=++*+-. .:=+**=: .-=***=. .:-+*#*-...:=+##*=::::-+##*+-:.. .-++++**##***++**#*+-::..:-+##*=-:. .=***+=: .-+*++-. :=++*+-. .-=+**+: :-=*#*=. .:=+##+ =+*+=: .-++**=. .:=+**+-. .-=+##+-..:-=*##+-:.:-=*##+-:...-+##*+=:. .:-==+*###**++++=-:..:::=*##*=-:. .-+**+=:. :=+*+=: .-=+**=: .-=***=. .:=+*#+-..:-=*##+ =+**+-. .-=+**=:..:-+*#*=:..:-+##*=:.::-+##*=::..-+##*=-:. .-++*+++-: .::::--====--:. .::-+*##*=-:. .-+**+=-. :=+*++-. :=++*+-. .:=+**+-. .-=+##+:..:-+*#*= -+*#*=...:=+##+-..:-=*##+-:.:-=###+-:..:=*#*+-:. .-+**+=-. .:=++*#*+-:::.. .::.. .:--=+###*=-:...-+**+=-: .-+*++=: .-=+**=: .-=+**=: .:-+*#*=:..:=+##*- -=*##=:..:-+##*=::::-+##*=::..-*##+=-. .-+**+=-. .-++**+-. .:-=*###*+=--:.....:::..:--=++*##*+-::..:-+##*=-: .-+**+=-. :=+**+-. .:=+*#+-...-=+##+-..:-=*##+- :=*##+-::::=*##+-:..:=*#*=-:. :=***+-: .-++++=-. :-=+*#*=:..:::-=****++*+++======++********=-:..::-=*##*=-:. .-+**++-. .-++**=: :-=***=:..:-=*#*=:..:-+##*=: :-+##*=-:..-+##+=-. .-+**+=:. :++*++-. :-++**+-. .:-=*##*+--:. .:==++*####**++*####**++==:. .:--+###*=-:. .-+**++-: .-=+**+: .-=+*#+-...-=+##+-..:-=*##+-: .:=*#*=-:. :=**+=-: :=+*++-. .-=+**+:. .:-+*##+-:::::=+##*+=-:. .:--==+**++++****+==--: :--=*###+=-:...-+**++-: .-=+**+-. :-+***=:..:-+*#*=:..:-+##*=:: .-+**+=:. .-+**+=: .-=+**+-. .:-+*#*+:..::-+###+=-:. .:=+***++=-:........::-----::::::.. :-==+*##*=-::..:=*#*+=-: .:=++++-. :-=+**+:..:-=*##+-..:-=*##+-:: :=+*++-. :=++*+=. :-=***+-..::=+##*=-::.:-+*#*+=-: :-=+*###*+=--:. ..:. .:::::-=+++****=-:..::-=*##+=-:. .-=+*++=: .-=+**+-. .:=+##*=:.::-+##*=::. .-=+**=: .-=+**+-...:-+##*=-::::=*##*=-:. .:=+*+++=:. .::-=+*##**++==--::::::...::---=+**#**+++=:. ..:-=+###+=-:. .-+**++=: .-=+**+-. .:-+*#*=:..:-=*##+-::: . :-+***=:..:-=*##+-:.::=*##*=-:..:-+**+=-: :-=+*#*+=:::...:-=++++*###**++=+++++++++**###*+==-:. .:-=+*##*+-::...-+**++-: .:=+**+=. :-=*##+-..::=*##*-::.:

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.

What changed since Oct 12

Key takeaways

Are Analyst Price Targets Accurate? 7 Years of Data

How to Follow Wall Street Analysts the Smart Way: Track Records, Not Headlines

What Are Exent Gems? Top‑Analyst Agreement Explained